Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gibberellic acid is a naturally occurring plant hormone (gibberellin) and a pentacyclic diterpene acid that promotes growth and elongation of cells in plants. It acts as a plant growth regulator by stimulating both cell division and cell elongation, affecting leaves, stems, fruit development, seed germination rates, and overall plant maturation. Gibberellic acid exerts its effects by altering gene transcription through inhibition of pathway inhibitors (a double-negative mechanism), leading to increased mRNA production for hydrolytic enzymes during seed germination. Industrially produced using microorganisms such as Gibberella fujikuroi (from which it was first isolated in Japan in 1926), it is widely used in agriculture for crops and ornamental plants[1][4][5][6]. In animal studies (rats), it has shown biological activity including acting as an agonist of steroidogenesis[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gibberellic acid.